首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

2065246

醫療模擬市場預測至2034年－按服務、技術、保真度、專業領域、應用、最終用戶和地區分類的全球分析

Medical Simulation Market Forecasts to 2034 - Global Analysis By Service, Technology, Fidelity, Specialty, Application, End User and By Geography

出版日期: 2026年06月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年全球醫療模擬市場規模將達到 36 億美元，到 2034 年將達到 91 億美元，預測期內複合年成長率為 12.3%。

醫學模擬是指一系列廣泛的教育工具、平台和服務，旨在模擬臨床場景、解剖結構和手術環境，用於培訓、評估和認證醫療專業人員，同時避免對實際患者造成風險。這些解決方案涵蓋範圍廣泛，從低保真度的解剖模型和部分任務訓練器，到高保真度的人體模型模擬器、虛擬實境（VR）手術平台以及人工智慧驅動的自適應訓練環境。

確保病人安全和改革基於能力的醫學教育的必要性。

鑑於全球醫療監管機構和認證機構持續關注住院醫師進入臨床實踐時操作技能的差異，他們正日益強制要求將模擬訓練作為醫學和外科教育課程的核心要素。為保護患者免受使用真實病例進行訓練可能造成的傷害，倫理方面的要求正在加速模擬環境的普及，使其成為臨床培訓前初始技能習得的主要場所。基於能力的醫學教育框架要求提供學員進展的客觀表現證據，這進一步增加了對能夠精確記錄和報告操作技能指標以用於評估和認證的模擬平台的需求。

營運模擬中心需要高昂的實施成本，並且會消耗大量資源。

高保真醫學模擬器需要大量的資金投入，每套系統的價格從數萬美元到數十萬美元不等，這使得許多低收入地區的教育和醫療機構難以負擔。除了購置設備外，營運模擬中心還需要持續投入教師時間、技術支援人員、耗材和設施維護費用，導致總擁有成本龐大，阻礙了其永續應用。小規模的醫療部門和社區醫院在論證投資模擬基礎設施以滿足培訓量需求方面面臨特殊的挑戰，往往只能使用低保真或共用模型進行模擬。

將虛擬實境和身臨其境型模擬技術引入外科手術培訓

虛擬實境（VR）手術模擬平台的快速成熟正在創造突破性的訓練機會，克服了實體模擬器方法的許多限制。 VR手術訓練器能夠實現手術操作的無限次重複練習，並提供詳細的操作回饋，無需耗材成本，並允許學員在結構化的模擬中心課程之外進行獨立練習。透過整合觸覺回饋、逼真的解剖渲染和人工智慧驅動的自適應難度調整，VR平台在實際手術環境的準備方面變得越來越有效。 VR模擬在腹腔鏡、內視鏡和機器人手術訓練的應用日益廣泛，加之硬體成本的下降，正大幅擴大全球醫學教育機構身臨其境型模擬技術的潛在市場。

關於模擬訓練能否轉化為臨床表現提升的證據有限。

儘管醫學模擬作為一種培訓方法已被廣泛推薦，但現有證據仍然不足以證明，透過模擬獲得的技能能夠可靠地改善臨床表現和患者預後，尤其是在多種手術類型和培訓情境下。一些醫學教育者和醫療系統管理者對模擬訓練的臨床投資報酬率持懷疑態度，導致他們在預算分配決策上猶豫不決。此外，不同供應商提供的模擬平台品質參差不齊，培訓方案的有效性也存在差異，這使得醫療機構難以自信地選擇已被證實有效的解決方案。因此，如何獲得可靠的前瞻性臨床證據，將模擬培訓的實施與患者照護品質的可衡量改善聯繫起來，仍然是模擬行業面臨的關鍵挑戰。

新型冠狀病毒（COVID-19）的影響

新冠疫情嚴重衝擊了全球模擬中心的運營，線下培訓被迫暫停，醫學生的臨床實習機會也大幅減少。疫情帶來的衝擊促使遠端和虛擬模擬能力迅速發展，教育機構紛紛尋求數位化替代方案，以在封鎖期間維持教學能力建設。線上模擬平台、虛擬病人互動工具和基於網路的程序培訓工具的需求顯著成長。疫情也凸顯了醫學模擬在幫助醫護人員掌握新的臨床場景方面的價值，例如新冠肺炎的呼吸系統護理和個人防護工具（PPE）的使用流程，再次強調了模擬在提升醫護人員的韌性和緊急應變能力方面的戰略重要性。

在預測期內，「高保真模擬器」細分市場預計將佔據最大的市場佔有率。

在預測期內，高保真模擬器預計將佔據最大的市場佔有率。這些先進的基於人體模型的平台能夠高度逼真地再現複雜的生理反應、操作流程和臨床惡化場景，從而支持團隊協作的臨床決策培訓、危機情況下的資源管理模擬以及高級操作技能的評估。護理、麻醉、急診醫學和外科培訓計畫中高保真模擬技術的廣泛應用，以及醫療機構對符合認證標準的要求，正推動著大學附屬醫院和大型醫院網路對這些高階模擬系統的強勁需求。

預計在預測期內，虛擬實境（VR）模擬領域將呈現最高的複合年成長率。

在預測期內，虛擬實境（VR）模擬領域預計將呈現最高的成長率。 VR顯示品質、觸覺回饋技術和手術操作保真度的快速發展，正在克服以往限制臨床訓練效果的傳統限制。除了無需更換耗材即可無限次重複操作此成本優勢外，VR平台還可根據需要部署，即使在專用模擬中心之外也能使用，這使其成為推動外科和手術操作培訓項目採用VR技術的有力理由。 VR培訓庫涵蓋的外科專科範圍不斷擴大，以及越來越多的證據支持VR培訓所習得技能的轉移，正在加速VR技術在全球醫學教育機構中的應用。

市佔率最大的地區

在預測期內，北美預計將佔據最大的市場佔有率。美國在全球醫療模擬技術應用方面處於領先地位，這得益於其大學附屬醫療中心高度發達的模擬中心基礎設施、聯合委員會和專科認證委員會對基於模擬的培訓的強力監管支持，以及機構對基於能力的醫學教育改革的大量投入。美國和加拿大擁有許多主要的醫療模擬設備製造商，確保了創新平台的新技術能夠迅速滲透到國內市場。軍事醫療模擬計畫作為重要的採購領域，也推動了北美市場的擴張。

複合年成長率最高的地區

在預測期內，亞太地區預計將呈現最高的複合年成長率。中國、印度、韓國和東南亞等地醫學院入學人數的快速成長、私人醫療培訓網路的蓬勃發展以及政府主導的醫療專業人員培訓舉措的推進，都催生了對基於模擬的培訓平台的強勁需求。各國醫療改革議程強調提高臨床能力標準和病人安全，推動了機構對模擬基礎設施的投資。該地區領先的教學醫院建立專門的醫學模擬中心，以及亞洲醫學教育者對模擬益處的日益認可，都是推動這一需求的關鍵因素。

免費客製化服務

所有購買此報告的客戶均可享受以下免費自訂選項之一。

企業概況
- 對其他市場參與企業（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 透過產品系列、地域覆蓋和策略聯盟對標領先企業。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
其他
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲地區

第12章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第13章：產業趨勢與策略舉措

併購
夥伴關係、聯盟、合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第14章：公司簡介

CAE Healthcare
Laerdal Medical
3D Systems Corporation
Gaumard Scientific
Kyoto Kagaku Co., Ltd.
Mentice AB
Surgical Science Sweden AB
Simulab Corporation
Limbs & Things Ltd.
Simulaids Inc.
3B Scientific GmbH
VirtaMed AG
TruCorp Ltd.
Intelligent Ultrasound Group plc
SimX Inc.

簡介目錄圖表

Product Code: SMRC36788

According to Stratistics MRC, the Global Medical Simulation Market is accounted for $3.6 billion in 2026 and is expected to reach $9.1 billion by 2034, growing at a CAGR of 12.3% during the forecast period. Medical Simulation encompasses a wide spectrum of educational tools, platforms, and services designed to replicate clinical scenarios, anatomical structures, and procedural environments for the training, assessment, and credentialing of healthcare professionals without risk to actual patients. These solutions range from low-fidelity anatomical models and part-task trainers to high-fidelity mannequin simulators, virtual reality surgical platforms, and AI-powered adaptive training environments.

Market Dynamics:

Driver:

Patient safety imperatives and competency-based medical education reforms

Healthcare regulatory bodies and accreditation organizations globally are increasingly mandating simulation-based training as a core component of medical and surgical education curricula in response to persistent concerns about procedural skill variability among trainees entering clinical practice. The ethical imperative to protect patients from harm associated with training on live cases is accelerating adoption of simulation environments as the primary venue for initial skill acquisition before supervised clinical exposure. Competency-based medical education frameworks that require objective performance evidence for trainee progression are further driving demand for simulation platforms capable of capturing and reporting granular procedural performance metrics for assessment and credentialing purposes.

Restraint:

High procurement costs and resource-intensive simulation center operations

High-fidelity medical simulators represent significant capital investments ranging from tens of thousands to hundreds of thousands of dollars per system, placing them beyond the budgetary reach of many educational institutions and healthcare organizations in lower-income regions. Beyond equipment acquisition, operating simulation centers requires ongoing investment in faculty time, technical support staff, consumable replacement supplies, and facility maintenance, creating a substantial total cost of ownership that limits sustainable adoption. Smaller medical schools and community hospitals face particular challenges in justifying simulation infrastructure investment relative to their training volume requirements, often limiting their simulation capabilities to lower-fidelity and shared-access models.

Opportunity:

Virtual reality and immersive simulation technology adoption in surgical training

The rapid maturation of virtual reality surgical simulation platforms is creating transformative training opportunities that overcome many limitations of physical simulator-based approaches. VR surgical trainers provide unlimited procedure repetitions with detailed performance feedback, eliminating consumable costs and enabling self-directed practice outside structured simulation center sessions. The incorporation of haptic feedback, photorealistic anatomical rendering, and AI-adaptive difficulty adjustment is making VR platforms increasingly effective as preparation for real surgical environments. Growing adoption of VR simulation for laparoscopic, endoscopic, and robotic procedure training, combined with declining hardware costs, is expanding the addressable market for immersive simulation technologies significantly across global medical training institutions.

Threat:

Limited evidence base for simulation transfer to clinical performance improvement

Despite widespread advocacy for medical simulation as a training modality, the evidence base demonstrating that simulation-acquired skills reliably transfer to improved clinical performance and patient outcomes remains incomplete for many procedure types and training contexts. Skepticism among some medical educators and health system administrators about the clinical return on simulation investment creates hesitancy in budget allocation decisions. Additionally, the heterogeneity of simulation platform quality and training protocol effectiveness across vendors makes it difficult for institutions to confidently select solutions with demonstrated outcome validity. Generating robust prospective clinical evidence linking simulation training exposure to measurable improvements in patient care quality remains a critical challenge for the simulation industry.

Covid-19 Impact:

The COVID-19 pandemic severely disrupted simulation center operations globally as facilities closed to in-person training and medical students faced significant reductions in clinical placement opportunities. This disruption simultaneously catalyzed rapid expansion of remote and virtual simulation capabilities as educational institutions sought digital alternatives to maintain competency development during lockdowns. Online simulation platforms, virtual patient encounter tools, and web-based procedural trainers experienced significant demand surges. The pandemic also highlighted medical simulation's value in preparing healthcare professionals for novel clinical scenarios including COVID-19 respiratory management and PPE donning procedures, reinforcing simulation's strategic importance in healthcare workforce resilience and emergency preparedness frameworks.

The High-Fidelity Simulators segment is expected to be the largest during the forecast period

The High-Fidelity Simulators segment is expected to account for the largest market share during the forecast period. These advanced mannequin-based platforms replicate complex physiological responses, procedural interactions, and clinical deterioration scenarios with sufficient realism to support team-based clinical decision making training, crisis resource management simulation, and advanced procedural skills assessment. The widespread adoption of high-fidelity simulation in nursing, anesthesia, emergency medicine, and surgical residency training programs, combined with institutional requirements for accreditation compliance, sustains strong demand for these premium simulation systems across academic medical centers and large hospital networks.

The Virtual Reality (VR) Simulation segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Virtual Reality (VR) Simulation segment is predicted to witness the highest growth rate. Rapid advances in VR display quality, haptic feedback technology, and procedural fidelity are overcoming earlier limitations that constrained clinical training effectiveness. The cost advantages of unlimited procedure repetitions without consumable replacement costs, combined with the ability to deploy VR platforms at the point of need outside dedicated simulation centers, are compelling adoption arguments for surgical and procedural training programs. Expanding surgical specialty coverage of VR training libraries and growing evidence supporting VR-trained skill transfer are accelerating adoption across medical education institutions globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The United States leads global adoption driven by a highly developed simulation center infrastructure within academic medical centers, strong regulatory support for simulation-based training from the Joint Commission and medical specialty boards, and substantial institutional investment in competency-based medical education reforms. The presence of leading medical simulation manufacturers headquartered in the United States and Canada ensures early domestic market penetration of new platform innovations. Military healthcare simulation programs, representing a significant procurement segment, further contribute to North American market volume.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapidly expanding medical school enrollments, growing private healthcare training institute networks, and government-led healthcare workforce development initiatives across China, India, South Korea, and Southeast Asia are generating strong demand for simulation-based training platforms. National healthcare reform agendas emphasizing clinical competency standards and patient safety improvements are driving institutional investment in simulation infrastructure. The establishment of dedicated medical simulation centers by leading teaching hospitals across the region and growing awareness of simulation benefits among Asian medical educators are key demand catalysts.

Key players in the market

Some of the key players in Global Medical Simulation Market include CAE Healthcare, Laerdal Medical, 3D Systems Corporation, Gaumard Scientific, Kyoto Kagaku Co., Ltd., Mentice AB, Surgical Science Sweden AB, Simulab Corporation, Limbs & Things Ltd., Simulaids Inc., 3B Scientific GmbH, VirtaMed AG, TruCorp Ltd., Intelligent Ultrasound Group plc, and SimX Inc.

Key Developments:

In January 2026, CAE Healthcare announced the launch of its Maestro AI-powered simulation management platform, incorporating real-time learner performance analytics, adaptive scenario difficulty algorithms, and automated competency gap identification capabilities. The platform enables simulation center directors to deliver personalized training pathways for medical residents and nursing students, reducing the time required to achieve competency milestones while providing detailed performance data supporting accreditation documentation requirements.

In February 2026, Surgical Science Sweden AB announced the acquisition of a VR surgical simulation company specializing in robotic surgery training platforms, expanding its portfolio to include da Vinci robotic system simulation capabilities. The acquisition positions Surgical Science to offer a comprehensive minimally invasive surgery training ecosystem spanning laparoscopic, endoscopic, and robotic procedural simulations, addressing growing demand from surgical training programs adopting multi-modal digital skill acquisition frameworks.

Services Covered:

Anatomical Models
Web-Based Simulation
Simulation Software
Simulation Training Services
High-Fidelity Simulators
Low-Fidelity Simulators
Virtual Reality (VR) Simulation
Augmented Reality (AR) Simulation

Technologies Covered:

Virtual Reality (VR)
Augmented Reality (AR)
Mixed Reality (MR)
Artificial Intelligence (AI)-Based Simulation
3D Printing Simulation
Cloud-Based Simulation

Fidelity Levels Covered:

Low-Fidelity Simulation
Medium-Fidelity Simulation
High-Fidelity Simulation

Specialties Covered:

Cardiology
Neurology
Orthopedics
Urology
Gastroenterology
Oncology
Pulmonology
Obstetrics & Gynecology

Applications Covered:

Surgical Training
Cardiovascular Simulation
Laparoscopic Training
Endoscopy Simulation
Ultrasound Simulation
Dental Simulation
Obstetrics & Gynecology Simulation
Emergency Care Simulation
Patient Monitoring Training

End Users Covered:

Academic Institutions
Hospitals and Healthcare Systems
Military Organizations
Research and Academic Centers
Emergency Medical Services (EMS)
Pharmaceutical and Biotechnology Companies

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Medical Simulation Market, By Service

5.1 Anatomical Models
5.2 Web-Based Simulation
5.3 Simulation Software
5.4 Simulation Training Services
5.5 High-Fidelity Simulators
5.6 Low-Fidelity Simulators
5.7 Virtual Reality (VR) Simulation
5.8 Augmented Reality (AR) Simulation

6 Global Medical Simulation Market, By Technology

6.1 Virtual Reality (VR)
6.2 Augmented Reality (AR)
6.3 Mixed Reality (MR)
6.4 Artificial Intelligence (AI)-Based Simulation
6.5 3D Printing Simulation
6.6 Cloud-Based Simulation

7 Global Medical Simulation Market, By Fidelity

7.1 Low-Fidelity Simulation
7.2 Medium-Fidelity Simulation
7.3 High-Fidelity Simulation

8 Global Medical Simulation Market, By Specialty

8.1 Cardiology
8.2 Neurology
8.3 Orthopedics
8.4 Urology
8.5 Gastroenterology
8.6 Oncology
8.7 Pulmonology
8.8 Obstetrics & Gynecology

9 Global Medical Simulation Market, By Application

9.1 Surgical Training
9.2 Cardiovascular Simulation
9.3 Laparoscopic Training
9.4 Endoscopy Simulation
9.5 Ultrasound Simulation
9.6 Dental Simulation
9.7 Obstetrics & Gynecology Simulation
9.8 Emergency Care Simulation
9.9 Patient Monitoring Training

10 Global Medical Simulation Market, By End User

10.1 Academic Institutions
10.2 Hospitals and Healthcare Systems
10.3 Military Organizations
10.4 Research and Academic Centers
10.5 Emergency Medical Services (EMS)
10.6 Pharmaceutical and Biotechnology Companies

11 Global Medical Simulation Market, By Geography

11.1 North America
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
11.2 Europe
- 11.2.1 United Kingdom
- 11.2.2 Germany
- 11.2.3 France
- 11.2.4 Italy
- 11.2.5 Spain
- 11.2.6 Netherlands
- 11.2.7 Belgium
- 11.2.8 Sweden
- 11.2.9 Switzerland
- 11.2.10 Poland
- 11.2.11 Rest of Europe
11.3 Asia Pacific
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 South Korea
- 11.3.5 Australia
- 11.3.6 Indonesia
- 11.3.7 Thailand
- 11.3.8 Malaysia
- 11.3.9 Singapore
- 11.3.10 Vietnam
- 11.3.11 Rest of Asia Pacific
11.4 South America
- 11.4.1 Brazil
- 11.4.2 Argentina
- 11.4.3 Colombia
- 11.4.4 Chile
- 11.4.5 Peru
- 11.4.6 Rest of South America
11.5 Rest of the World (RoW)
- 11.5.1 Middle East
  - 11.5.1.1 Saudi Arabia
  - 11.5.1.2 United Arab Emirates
  - 11.5.1.3 Qatar
  - 11.5.1.4 Israel
  - 11.5.1.5 Rest of Middle East
- 11.5.2 Africa
  - 11.5.2.1 South Africa
  - 11.5.2.2 Egypt
  - 11.5.2.3 Morocco
  - 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives

14 Company Profiles

14.1 CAE Healthcare
14.2 Laerdal Medical
14.3 3D Systems Corporation
14.4 Gaumard Scientific
14.5 Kyoto Kagaku Co., Ltd.
14.6 Mentice AB
14.7 Surgical Science Sweden AB
14.8 Simulab Corporation
14.9 Limbs & Things Ltd.
14.10 Simulaids Inc.
14.11 3B Scientific GmbH
14.12 VirtaMed AG
14.13 TruCorp Ltd.
14.14 Intelligent Ultrasound Group plc
14.15 SimX Inc.

簡介目錄圖表

List of Tables

Table 1 Global Medical Simulation Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Medical Simulation Market Outlook, By Service (2023-2034) ($MN)
Table 3 Global Medical Simulation Market Outlook, By Anatomical Models (2023-2034) ($MN)
Table 4 Global Medical Simulation Market Outlook, By Web-Based Simulation (2023-2034) ($MN)
Table 5 Global Medical Simulation Market Outlook, By Simulation Software (2023-2034) ($MN)
Table 6 Global Medical Simulation Market Outlook, By Simulation Training Services (2023-2034) ($MN)
Table 7 Global Medical Simulation Market Outlook, By High-Fidelity Simulators (2023-2034) ($MN)
Table 8 Global Medical Simulation Market Outlook, By Low-Fidelity Simulators (2023-2034) ($MN)
Table 9 Global Medical Simulation Market Outlook, By Virtual Reality (VR) Simulation (2023-2034) ($MN)
Table 10 Global Medical Simulation Market Outlook, By Augmented Reality (AR) Simulation (2023-2034) ($MN)
Table 11 Global Medical Simulation Market Outlook, By Technology (2023-2034) ($MN)
Table 12 Global Medical Simulation Market Outlook, By Virtual Reality (VR) (2023-2034) ($MN)
Table 13 Global Medical Simulation Market Outlook, By Augmented Reality (AR) (2023-2034) ($MN)
Table 14 Global Medical Simulation Market Outlook, By Mixed Reality (MR) (2023-2034) ($MN)
Table 15 Global Medical Simulation Market Outlook, By Artificial Intelligence (AI)-Based Simulation (2023-2034) ($MN)
Table 16 Global Medical Simulation Market Outlook, By 3D Printing Simulation (2023-2034) ($MN)
Table 17 Global Medical Simulation Market Outlook, By Cloud-Based Simulation (2023-2034) ($MN)
Table 18 Global Medical Simulation Market Outlook, By Fidelity (2023-2034) ($MN)
Table 19 Global Medical Simulation Market Outlook, By Low-Fidelity Simulation (2023-2034) ($MN)
Table 20 Global Medical Simulation Market Outlook, By Medium-Fidelity Simulation (2023-2034) ($MN)
Table 21 Global Medical Simulation Market Outlook, By High-Fidelity Simulation (2023-2034) ($MN)
Table 22 Global Medical Simulation Market Outlook, By Specialty (2023-2034) ($MN)
Table 23 Global Medical Simulation Market Outlook, By Cardiology (2023-2034) ($MN)
Table 24 Global Medical Simulation Market Outlook, By Neurology (2023-2034) ($MN)
Table 25 Global Medical Simulation Market Outlook, By Orthopedics (2023-2034) ($MN)
Table 26 Global Medical Simulation Market Outlook, By Urology (2023-2034) ($MN)
Table 27 Global Medical Simulation Market Outlook, By Gastroenterology (2023-2034) ($MN)
Table 28 Global Medical Simulation Market Outlook, By Oncology (2023-2034) ($MN)
Table 29 Global Medical Simulation Market Outlook, By Pulmonology (2023-2034) ($MN)
Table 30 Global Medical Simulation Market Outlook, By Obstetrics & Gynecology (2023-2034) ($MN)
Table 31 Global Medical Simulation Market Outlook, By Application (2023-2034) ($MN)
Table 32 Global Medical Simulation Market Outlook, By Surgical Training (2023-2034) ($MN)
Table 33 Global Medical Simulation Market Outlook, By Cardiovascular Simulation (2023-2034) ($MN)
Table 34 Global Medical Simulation Market Outlook, By Laparoscopic Training (2023-2034) ($MN)
Table 35 Global Medical Simulation Market Outlook, By Endoscopy Simulation (2023-2034) ($MN)
Table 36 Global Medical Simulation Market Outlook, By Ultrasound Simulation (2023-2034) ($MN)
Table 37 Global Medical Simulation Market Outlook, By Dental Simulation (2023-2034) ($MN)
Table 38 Global Medical Simulation Market Outlook, By Obstetrics & Gynecology Simulation (2023-2034) ($MN)
Table 39 Global Medical Simulation Market Outlook, By Emergency Care Simulation (2023-2034) ($MN)
Table 40 Global Medical Simulation Market Outlook, By Patient Monitoring Training (2023-2034) ($MN)
Table 41 Global Medical Simulation Market Outlook, By End User (2023-2034) ($MN)
Table 42 Global Medical Simulation Market Outlook, By Academic Institutions (2023-2034) ($MN)
Table 43 Global Medical Simulation Market Outlook, By Hospitals and Healthcare Systems (2023-2034) ($MN)
Table 44 Global Medical Simulation Market Outlook, By Military Organizations (2023-2034) ($MN)
Table 45 Global Medical Simulation Market Outlook, By Research and Academic Centers (2023-2034) ($MN)
Table 46 Global Medical Simulation Market Outlook, By Emergency Medical Services (EMS) (2023-2034) ($MN)
Table 47 Global Medical Simulation Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)